All Viruses articles – Page 100
-
NewsResearchers develop electrochemical biosensor for flu antibody detection
A new testing method uses an electrochemical cell-free biosensor that can directly detect antibodies against diseases such as influenza in blood serum.
-
NewsChange in genetics of SARS-CoV-2 evolved to counter weakness caused by the virus’s initial mutation
Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.
-
NewsDifferences in gut microbiome linked to risk of death in COVID-19 patients with respiratory failure
A new study finds differences in gut bacteria and metabolites among COVID-19 patients admitted to the ICU, offering possibilities for preventing the worst outcomes.
-
NewsSimple nasal swab can provide early warning of emerging viruses
Testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses not identified in standard tests, Yale researchers have found.
-
-
NewsScientists create deep red cranberry lipstick with antimicrobial properties
Researchers have developed a deep red lipstick with antimicrobial properties by adding cranberry extract to the formulation.
-
NewsOlfactory viral inflammation linked to accelerated onset of Alzheimer’s disease
Viruses can inflame and disrupt connections between the olfactory system, which governs the sense of smell, and the part of the brain associated with memory and learning, possibly accelerating the onset of Alzheimer’s disease, according to a new study.
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
-
NewsPhase 2 trial of Ebola vaccines yields promising results
An international team of scientists has published the results of a large-scale randomized clinical trial in West Africa which confirms the safety of three vaccine regimens for Ebola and suggests an immune response is induced and maintained for up to 12 months.
-
NewsResearchers infect ‘brain in a dish’ in pursuit of Zika antivirals
A University of Queensland-led project has used a ‘brain in a dish’ to study the effects of the Zika virus, taking research a step closer towards developing drugs to combat the infection.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
-
News New virus discovered in Swiss ticks
Researchers from the Institute of Virology at the University of Zurich (UZH) have detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
-
NewsLiquid-coated air filter inspired by carnivorous plant can improve early capture of airborne pathogens
Researchers have designed a new liquid-coated air filter that allows for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsWireless device can rapidly spot coronavirus using magnetostrictive composite plates
A collaborative research group has engineered a self-sustaining device that can immediately detect COVID-19 particles in its surroundings.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.